Revimmune Uses An Approved Drug In A New Patent-Pending Method To ... - Medical News Today (press release)
March 3, 2007| Revimmune Uses An Approved Drug In A New Patent-Pending Method To ... Medical News Today (press release), UK - Investigators have reported favorable case experience with refractory scleroderma, acquired pemphigus, rheumatoid arthritis, and Crohn's Disease. ... Accentia gets global license to Revimmune |
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ... - PipelineReview.com (press release)
March 3, 2007| HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ... PipelineReview.com (press release), Spain - The safety profile of HUMIRA in the Crohn's clinical trials was similar to that seen in HUMIRA clinical trials for rheumatoid arthritis (RA). ... |
Biologic Humira Approved for Treatment of Crohn's Disease - Biologic Drug Report
March 3, 2007 Playfuls.com | Biologic Humira Approved for Treatment of Crohn's Disease Biologic Drug Report, FL - Humira (adalimumab), a biologic response modifier widely used for treatment of adult patients with moderate to severe rheumatoid arthritis, was approved by ... HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ... New Crohn's disease treatment Humira promises to reduce symptoms FDA Approves New Treatment For Crohn’s Disease |